Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
75 hedge funds and large institutions have $143M invested in Immunomedics Inc in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 14 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 18
1% less capital invested
Capital invested by funds: $145M → $143M (-$2M)
7% less funds holding
Funds holding: 81 → 75 (-6)
34% less call options, than puts
Call options by funds: $4.33M | Put options by funds: $6.57M
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$13M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
+$7.25M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.49M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.41M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$842K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$6.43M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.81M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.28M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.01M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$994K |
IMMU Hedge Fund Activity: Q1 2014 in Review
75 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2014, worth a combined $143M — down 1.4% from $145M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of IMMU and 8 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 27 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $13M. The largest seller was SAC Capital Advisors, exiting entirely with an estimated $6.43M sold.
- 75 institutional investors held Immunomedics Inc (IMMU) as of Q1 2014, down from 81 in Q4 2013.
- Funds reported $143M of Immunomedics Inc stock for Q1 2014, down 1.4% quarter-over-quarter.
- 8 funds opened new Immunomedics Inc positions in Q1 2014 and 14 closed out, a net change of -6 holders.
- The largest Immunomedics Inc buyer in Q1 2014 was Deerfield Management, an estimated $13M added.
- The largest Immunomedics Inc seller in Q1 2014 was SAC Capital Advisors, an estimated $6.43M sold.
Based on aggregated 13F filings for Q1 2014.